2016
DOI: 10.1039/c6tb01946c
|View full text |Cite
|
Sign up to set email alerts
|

Blood clot initiation by mesoporous silica nanoparticles: dependence on pore size or particle size?

Abstract: The hemostatic efficiency of mesoporous silica nanoparticles depends on pore size more than particle size, and biocompatibility is more related to particle size.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
49
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 76 publications
(57 citation statements)
references
References 32 publications
2
49
0
Order By: Relevance
“…In contrast, more pseudopod platelets were presented on the surface of 2%CDDs, the quantity of pseudopod platelets was further increased in the 2%CDDs‐30%TBA, 2%CDDs‐60%TBA, and 2%CDDs‐100%TBA groups, indicating their outstanding ability to induce platelet adhesion and activation, which proved their higher hemostatic efficiency. [ 27 ] Surface negative charge of DB in CDDs‐TBA could activate intrinsic coagulation pathway to enhance platelet adhesion and aggregation. Moreover, the hierarchical porous structure of DB and chitosan matrix could concentrate functional proteins in plasma, thus further promote platelet adhesion and activation.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, more pseudopod platelets were presented on the surface of 2%CDDs, the quantity of pseudopod platelets was further increased in the 2%CDDs‐30%TBA, 2%CDDs‐60%TBA, and 2%CDDs‐100%TBA groups, indicating their outstanding ability to induce platelet adhesion and activation, which proved their higher hemostatic efficiency. [ 27 ] Surface negative charge of DB in CDDs‐TBA could activate intrinsic coagulation pathway to enhance platelet adhesion and aggregation. Moreover, the hierarchical porous structure of DB and chitosan matrix could concentrate functional proteins in plasma, thus further promote platelet adhesion and activation.…”
Section: Resultsmentioning
confidence: 99%
“…Clinical Standard Coagulation Tests : The coagulation tests including aPTT, PT, TT, and Fbg were conducted using an automatic coagulation analyzer (CA‐7000, Sysmex medical electronics (Shanghai) Co., Ltd.) according to the procedure published previously . For PT, TT, and Fbg measurement, 500 µL of PPP and sample (5 mg mL −1 ) were mixed and incubated at 37 °C for 3 min, then centrifugated and measured by automatic coagulation analyzer.…”
Section: Methodsmentioning
confidence: 99%
“…Early intervention to halt bleeding during the first few minutes after injury is critical for improving the chances of survival. Several topical hemostats based on organic polymers and inorganic micro‐/nanometer materials have been developed . Since the U.S. Food and Drug Administration (FDA) approved QuikClot, a zeolite‐based externally applied hemostat in 2002, there has been considerable interest in natural nanoclay minerals for the management of massive hemorrhage–especially for battlefield trauma–owing to their high absorption and biological inertness .…”
Section: Introductionmentioning
confidence: 99%
“…It is worth noting that KEM 1.5 showed the best hemostasis capability among all the NEMs, which reaches the 'standard of care' level for commercial products (ClG and CoG) in the three in vivo bleeding models (Fig. 4a), varied from those reported nanoclay-containing composites 13,14,16,19 , inorganic nanoparticles 44 and other hemostatic materials 5,6,45,46 that involve poor mechanical strength and inflammation and thrombosis risk due to fine particles or the particles exfoliation from incompact structure (Supplementary Table 2).…”
Section: Resultsmentioning
confidence: 87%